These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25228550)

  • 1. The challenges and perspectives in treating adolescent and young adult patients with hematological malignancies.
    Raanani P; Tallman MS
    Acta Haematol; 2014; 132(3-4):263. PubMed ID: 25228550
    [No Abstract]   [Full Text] [Related]  

  • 2. High susceptibility to severe infectious complications at reinduction chemotherapy in patients who relapse after stem cell transplantation.
    Iguchi A; Kobayashi R; Sato TZ; Naito H; Shikano T; Ishikawa Y; Kobayashi K
    Transplant Proc; 2010 Jun; 42(5):1857-61. PubMed ID: 20620537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients.
    Quaglino P; Nardò T; Fierro MT; Massaia M; Orsucci L; Fava P; Marenco F; Marra E; Savoia P; Vitolo U; Boccadoro M; Bernengo M
    G Ital Dermatol Venereol; 2013 Oct; 148(5):453-63. PubMed ID: 24005137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
    Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
    Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chemotherapy on plasma lipids and lipoproteins in Nigerian patients with haematological malignancy.
    Idogun SE; Omoti CE
    Niger Postgrad Med J; 2011 Mar; 18(1):16-9. PubMed ID: 21445108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis.
    Hong M; Wu Q; Hu C; Fang J; You Y; Zhong Z; Zou P; Hu Y; Xia L
    Bone Marrow Transplant; 2012 Feb; 47(2):196-202. PubMed ID: 21441957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
    Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
    Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
    Fernández A; De Arriba F; Rivera J; Heras I; Vicente V; Lozano ML
    Haematologica; 2008 Sep; 93(9):1436-8. PubMed ID: 18641021
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum selenium deficiency in patients with hematological malignancies: is a supplementation study mandatory?
    Muecke R; Micke O; Schomburg L; Buentzel J; Adamietz IA; Huebner J;
    Acta Haematol; 2014; 132(2):256-8. PubMed ID: 24903215
    [No Abstract]   [Full Text] [Related]  

  • 10. New perspectives in the treatment of hematological malignancies.
    Kizaki M
    Curr Pharm Biotechnol; 2006 Oct; 7(5):313. PubMed ID: 17076646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the causes of death in the treatment of hematological malignancies with allogeneic stem cell transplantation from sibling donor].
    Yang SL; Li QC; Lai YR
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):120-1. PubMed ID: 21429381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].
    Ji Y; Xu LP; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):473-7. PubMed ID: 23827099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha2 in the treatment of hematological malignancies. Status and perspectives.
    Hasselbalch HC
    Curr Drug Targets; 2011 Mar; 12(3):387-91. PubMed ID: 21143152
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematological malignancies: a primer.
    Haddad RY
    Dis Mon; 2012 Apr; 58(4):151-2. PubMed ID: 22449364
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hematopoietic stem cell transplantation for hematological malignancies].
    Zhong MZ; Chen FP; Shu YG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):242-4. PubMed ID: 12575304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effects of treatments for hematological malignancies on prepubertal growth.
    Pearce MS
    Pediatr Hematol Oncol; 2000 Sep; 17(6):441-3. PubMed ID: 10989463
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
    Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
    Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hematologic malignancies/pediatric malignancies].
    Usui N
    Gan To Kagaku Ryoho; 2012 May; 39(5):731. PubMed ID: 22701898
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy in elderly patients with hematological malignancies].
    Ohnishi K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1586-90. PubMed ID: 21996952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of mTOR inhibitors as therapeutic agents in hematological malignancies.
    Sankhala K; Giles FJ
    Expert Rev Hematol; 2009 Aug; 2(4):399-414. PubMed ID: 21082945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.